About this scheme
PLI Scheme for Pharmaceuticals targets bulk drugs (APIs), KSMs, drug intermediates, and complex generic drugs. Tiered incentives 4-10% depending on category. Total outlay Rs. 15,000 Cr over 6 years.
What you get
- 4% incentive on fermentation-based bulk drugs
- 8-10% incentive on complex generic drugs
- 6% incentive on chemical-synthesis APIs
- 6-year incentive period
- Tax-free incentive disbursement
- Convergence with state pharma cluster schemes
Who qualifies
Indian and foreign pharma manufacturers committing fresh investment in 41 specified products. Three categories — bulk drug KSMs/DIs/APIs, complex generic drugs, in-vitro diagnostics. Minimum investment Rs. 5-1,000 Cr by category.
Industries (NIC divisions)
ChemicalsPharma
Business types
Private LimitedLLPsPublic Limited
Available across India (central scheme).
How to apply
- 1Apply during Department of Pharmaceuticals open window
- 2Submit detailed project + product specs
- 3Selection by Empowered Committee
- 4Plant commissioning + production start
- 5Annual production verification
- 6Incentive credited within 90 days post audit
Key terms and conditions
- Minimum threshold investment + production
- Year-on-year incremental sales target
- Sale to domestic market eligible
- 5-year continuity post-incentive
What disqualifies you
- Re-export only excluded
- Pure trading excluded
- Importing brands without manufacturing excluded
Documents typically required
- Investment plan
- Product specifications
- Annual production data
- Audited financials
The content above is compiled from public information published by the scheme authority. Eligibility, benefits, and procedures are subject to change. Confirm details directly with the official portal before applying. BharatSeal does not process scheme applications.